SpaceOAR Hydrogel is an absorbable gel material that creates a temporary space between the prostate and the rectum, potentially reducing radiation dose to the rectum during prostate cancer radiation. It separates the prostate and rectum and is naturally absorbed by the body in about six months.
SpaceOAR Hydrogel is an option for men preparing to undergo radiation treatment for prostate cancer. It is designed to reduce the radiation dose delivered to the rectum and help maintain rectal function.
When treating prostate cancer patients with radiation therapy, the goal is to kill the cancer cells while avoiding damage to surrounding healthy tissue.
The benefits of SpaceOAR Hydrogel, including a reduction of rectal injury resulting in maintained bowel function and a higher likelihood to maintain urinary and sexual function.
To date, more than 50,000 patients around the world have been successfully treated with SpaceOAR Hydrogel.
SpaceOAR Hydrogel can be implanted during a minimally invasive outpatient procedure, and patients typically experience little discomfort. It is typically not a lengthy procedure – usually about 30 minutes.
The SpaceOAR Hydrogel is injected as liquid through a needle placed between the rectum and the prostate. It can be implanted under general anesthesia that will put a patient to sleep during the procedure or a local anesthetic that will numb the injection area.
SpaceOAR Hydrogel stays in place for about three months. After about six months, the hydrogel is naturally absorbed into the body and removed through urine.
SpaceOAR Hydrogel is covered by many insurance plans and is reimbursed by Medicare on a case-by-case basis. Patients should verify their benefits with their insurance company in advance of the scheduled procedure.
